591 posts categorized "USciences"

01/08/2019

The Citizens' Voice: Naloxone can be a legitimate lifesaver

Gretchen Welby P’92 contributed to a column on the lifesaving effects of Naloxone. The column was circulated by The Citizens’ Voice in Wilkes Barre and the Scranton Times-Tribune in Scranton. It was also published online.

01/07/2019

Philly.com: Sensitivity needed if city wants positive results from banning nicotine in drug rehabs | Opinion

Robert Ashford, a recovery scientist at the USciences Substance Use Disorders Institute, wrote an op-ed on Philadelphia banning tobacco use at mental health facilities, including city-funded inpatient substance use disorder programs. The piece was published in the Inquirer and on Philly.com.

12/13/2018

Various Publications: Weber Scientific licenses new beer spoilage detection product

Multiple publications published a press release or wrote an article about a license agreement between Weber Scientific and USciences. Matthew Farber, Director of the Brewing Science Certificate Program, and undergraduate researcher, Kent Pham, invented a product that will help prevent costly brewery recalls by detecting a beer contaminant. The discovery and product was covered by Craft Brewing Business, Brewbound, the Philadelphia Business Journal and more.

12/10/2018

National Review: Two Ladies of the Southern Pantheon: Flannery O’Connor and Caroline Gordon

National Review’s Stephen Mirarchi shared his take on The Letters of Flannery O’Connor and Caroline Gordon written by Associate Professor of English, Christine Flanagan. “In the meantime, Flanagan’s extensive research and graceful, detailed notes will give O’Connor fans of all stripes new material on which to ruminate — and it may just inspire a few professors to add Gordon’s Malefactors to their American literature syllabi.”

SevenFifty Daily: New Test May Prevent Exploding Beer Bottles

Matt Farber, the director of the Brewing Science Certificate Program, has created a medium to detect a beer contaminant that has led to million-dollar recalls in recent years. SevenFifty Daily’s Tara Nurin details Dr. Farber’s new test, which has been licensed to Weber Scientific, called Farber Pham Diastaticus Medium.

News about Dr. Farber's invention was shared on Craft Brewing Business

12/04/2018

Various publications: Scott Jackson, Veteran Biopharmaceutical Executive, Joins GlycoMimetics Board of Directors

Scott Jackson P’88 has been named to the GlycoMimetics Board of Directors.  Jackson is the former Chief Executive Officer of Celator Pharmaceuticals, Inc.  

KYW Newsradio: University of the Sciences women's hoops rolling in early going

KYW’s Matt Leon interviewed women’s basketball coach Jackie Hartzell about the hot start to the Devil’s season.
 
"Our kids worked really hard in the offseason, and experiencing success the past two years has definitely made them hungry to experience more success," Hartzell said. "So far, pretty happy with the start."   

11/02/2018

Community News: New owners for Hopewell Pharmacy

Hopewell Pharmacy has been run for 31 years by James Palmieri and Gene Ragazzo, best friends who roomed together as students at Philadelphia College of Pharmacy and Science. However, when Palmieri bought out Ragazzo’s stake in the business four years ago, he approached his niece, JoAnn Hobson, also a USciences graduate, about selling the pharmacy to her. Hobson and her business partner took over ownership on August 31.  Read more about the community pharmacy legacy reported on by Community News Service.

10/30/2018

Alumna Jocelyn Konrad, Rite Aid Applauds New Law Signed By President Trump to Help Fight Opioid Abuse

Rite Aid Executive Vice President of Pharmacy Jocelyn Konrad P’92 was recognized at the White House last week as President Donald J. Trump signed the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) for Patients and Communities Act.

10/29/2018

Main Line News: Rosemont, USciences announce doctor of pharmacy partnership

Rosemont and USciences have announced a doctor of pharmacy partnership, Main Line Media News reported. Eligible students will study at Rosemont College for three years then have the option to apply and transfer to the USciences’ PharmD program.